Agenda
- Introductions-Ryan McDonough and Nirali Shah
- T1D Exchange Updates- Emma
- BPA project update- Dr. Wolf
- AID project update- T1D Exchange Team
Type 1 Diabetes Mapping Updates
- 43 centers fully mapped (from 37 centers in Q4)
- 6 in validation phase
Type 2 Diabetes Mapping Update
- 3 centers fully mapped
- 7 centers still in the mapping process
T1D Exchange Project Updates
Breakthrough T1D BPA Project Update
Aim 1: To develop and implement an EHR-based BPA using stakeholder feedback to standardize the approach for prescribing and documenting advanced diabetes technologies (ADT) (CGM, insulin pump, AID) among adult and pediatric PwT1D.
Aim 2: To determine the effectiveness of an EMR-based BPA in reducing racial inequities in ADT.
Aim 3: To explore the reasons identified for providers decision to not prescribe ADT and whether they were PwT1D or provider led, and the association between the reason provided and the PwT1D’s race/ethnicity.
Medtronic AID Project
Aim 1: Increase the percentage of T1DX-QI centers reporting AID system use and analyze real world data on AID use trends.
Aim 2: Complete qualitative analysis to understand factors that influence diabetes providers recommendations of AID systems.
Aim 3: Increase the percentage of newly diagnosed patients prescribed AID.
- 12 participating centers
Aim 1:
- T1D Exchange will work with T1DX-QI center teams that are fully data mapped to enhance AID data collection.
- Additionally, T1D Exchange’s Data Science Committee (DSC) will propose best practice recommendations for documenting AID use in EMRs outside of the T1DX-QI network, enhancing standardization of data collection.
- The participating centers will begin to report these metrics, if they have not in the past, or enhance their current reporting on these AID variables.
- T1D Exchange will analyze the expanded AID real world data, examining new trends and insights.